Dupilumab modulates specific IgE mite responses at the molecular level in severe T2-high atopic dermatitis: A real-world experience

BACKGROUND: Atopic dermatitis (AD) is regarded as a chronic systemic disease which is characterized by a robust overexpression of type 2 related cytokines, with increased total IgE levels and a concomitant sensitization to common allergens. Dupilumab, a fully human monoclonal antibody (mAb) to IL-4R...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Pérez, Ruperto, Poza-Guedes, Paloma, Mederos-Luis, Elena, Sánchez-Machín, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411935/
https://www.ncbi.nlm.nih.gov/pubmed/36035412
http://dx.doi.org/10.3389/fmed.2022.939598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411935/
https://www.ncbi.nlm.nih.gov/pubmed/36035412
http://dx.doi.org/10.3389/fmed.2022.939598

Ejemplares similares